No Data
Denali Therapeutics Is Maintained at Buy by Jefferies
Jefferies Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $45
Denali Recycles 14 Billion Pounds of Organic Materials, Including 1.7 Billion Pounds of Food Waste in a Single Year
AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com
We're Keeping An Eye On Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate
Denali Therapeutics Insider Sold Shares Worth $1,107,600, According to a Recent SEC Filing
No Data
No Data